High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (4) , 554-558
- https://doi.org/10.1016/s0959-8049(05)80150-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Multidrug ResistancePublished by Springer Nature ,2011
- Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis.Journal of Histochemistry & Cytochemistry, 1991
- Does P-Glycoprotein Predict Response to Chemotherapy, and If So, Is There a Reliable Way to Detect It?JNCI Journal of the National Cancer Institute, 1991
- Overexpression of P-glycoprotein rat hepatocellular carcinomas induced with N-nitrosomorpholineCarcinogenesis: Integrative Cancer Research, 1990
- Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex methodEuropean Journal of Cancer and Clinical Oncology, 1989
- Tamoxifen therapy in advanced/recurrent endometrial carcinomaGynecologic Oncology, 1989
- An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) geneCell, 1988
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985